Clinical Trials Browser

Phase 3 × Leukemia × Histamine × Clear all

NCT00003991 2013-11-06

Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia

Phase 3 Completed

Other hematologic neoplasm

Leukemia